Invesco’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.33M Buy
93,894
+5,037
+6% +$130K ﹤0.01% 2476
2025
Q4
$2.26M Buy
88,857
+12,255
+16% +$273K ﹤0.01% 2568
2025
Q3
$1.23M Buy
76,602
+9,852
+15% +$159K ﹤0.01% 2834
2025
Q2
$1.07M Buy
66,750
+11,438
+21% +$173K ﹤0.01% 2818
2025
Q1
$945K Sell
55,312
-448,720
-89% -$9.39M ﹤0.01% 2855
2024
Q4
$12.5M Sell
504,032
-90,210
-15% -$2.56M ﹤0.01% 1721
2024
Q3
$16.9M Buy
594,242
+23,344
+4% +$688K ﹤0.01% 1552
2024
Q2
$15.1M Buy
570,898
+44,665
+8% +$1.27M ﹤0.01% 1570
2024
Q1
$17M Buy
526,233
+34,118
+7% +$1.24M ﹤0.01% 1530
2023
Q4
$20.7M Buy
492,115
+253,060
+106% +$9.31M ﹤0.01% 1387
2023
Q3
$9.18M Buy
239,055
+216,455
+958% +$4.89M ﹤0.01% 1819
2023
Q2
$429K Buy
22,600
+6,563
+41% +$122K ﹤0.01% 3324
2023
Q1
$249K Sell
16,037
-825
-5% -$14.3K ﹤0.01% 3556
2022
Q4
$299K Buy
16,862
+828
+5% +$10.4K ﹤0.01% 3508
2022
Q3
$89K Sell
16,034
-209
-1% -$1.02K ﹤0.01% 3856
2022
Q2
$63K Sell
16,243
-2,457
-13% -$10.6K ﹤0.01% 3947
2022
Q1
$103K Buy
18,700
+711
+4% +$4.43K ﹤0.01% 3865
2021
Q4
$153K Sell
17,989
-2,935
-14% -$24.2K ﹤0.01% 3838
2021
Q3
$182K Sell
20,924
-841,089
-98% -$7.59M ﹤0.01% 3834
2021
Q2
$9.11M Buy
862,013
+2,151
+0.3% +$30K ﹤0.01% 2107
2021
Q1
$13.8M Sell
859,862
-267,625
-24% -$7.06M ﹤0.01% 1764
2020
Q4
$52.1M Buy
1,127,487
+882,862
+361% +$40.8M 0.02% 1007
2020
Q3
$8.61M Buy
244,625
+94,776
+63% +$2.85M ﹤0.01% 1727
2020
Q2
$3.65M Buy
+149,849
New +$3.21M ﹤0.01% 2169

Other funds holding IMVT